Lipid signaling in Hippo pathway regulation
Lipid signaling in Hippo pathway regulation
批准号:
10330372
负责人:
Wenqi Wang
金额:
$30.9万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-02-01 至 2023-01-31
关键词:
ActinsAddressApoptosisBindingCell NucleusCell PolarityCell ProliferationComplexContact InhibitionCytoskeletonDataDrosophila genusEnzymesEventF-ActinG Protein-Coupled Receptor SignalingGene SilencingGenetic TranscriptionGoalsGrowth FactorHomeostasisHormonesHypoxiaInterleukin-2KnowledgeLATS1 geneLipidsMammalsMediatingMediator of activation proteinMetabolicModelingNeurofibromin 2NuclearNuclear TranslocationOrganOrgan SizePathway interactionsPhosphatidic AcidPhospholipidsPhosphorylationPhosphotransferasesPlayPolymersProductionProteomicsRegulationResearchResistanceRoleSecond Messenger SystemsSignal PathwaySignal TransductionStimulusStressTissuesbasecell growthextracellularmechanical signalnovelphospholipase D1protein functionresponserhorho GTP-Binding Proteinstranscription factorupstream kinase
中文摘要
项目摘要
在过去的几十年里,Hippo通路被认为是一种重要的信号通路,
通过限制细胞增殖和抗凋亡来控制器官和组织的大小。Hippo途径可以是
由广泛的细胞外信号调节,包括来自细胞的感知物理信号
微环境(即接触抑制,细胞极性,基于细胞骨架的机械线索),生长
因子/促有丝分裂激素(即LPA和S1 P调节的GPCR信号传导),以及最近发现的代谢
状态(即能量应激、缺氧)。机械地,几乎所有这些刺激或条件操作雅普活动
LATS 1/2激酶。目前Hippo信号的主要知识差距来自于
LATS 1/2调节的未表征机制。本提案的总体目标是阐明
LATS 1/2激酶对Hippo上游信号事件的响应的调节机制。
LATS 1/2激酶的详细调节机制可能是复杂的,因为多个上游调节机制可能是复杂的。
包括MST 1/2、MAP 4Ks、TAO 1-TAO 3在内的激酶能够磷酸化LATS 1/2,并且是LATS 1/2所需的
activation.目前还不清楚这些已鉴定的激酶是如何协调上游信号传导,
激活LATS 1/2。此外,小的Rho GT3与F-β肌动蛋白一起可以感知上游信号,从而调节
然而,LATS 1/2活动的潜在机制也在很大程度上是未知的。因此,在过去的几年里,
多年来,我们对Hippo通路中的主要组分和调控因子进行了蛋白质组学分析
去寻找这些问题的答案不幸的是,我们的发现和其他实验室的发现都失败了
确定这样一个假定的“调解人”,以填补目前的知识差距,在河马途径。竟然和
令人兴奋的是,我们的初步研究已经发现磷脂酸(PA)及其相关的脂质信号转导作为一种
参与Hippo通路调节的关键信号轴。PA可以作为第二信使,
与LATS 1/2激酶直接相关并调节LATS 1/2活性。值得注意的是,PA的水平以及
PLD 1是催化PA产生的关键酶,其活性均在对Hippo-1的反应中降低。
激活刺激或条件。基于这些观察,我们假设PLD 1-β-PA轴可能
在规范LATS 1/2活动方面发挥关键作用。具体而言,我们建议1)确定PA在以下方面的作用:
雅普调节,特别关注PA与LPA在雅普激活中的独立作用;
PA激活雅普的机制。我们将通过PA在LATS 1/2抑制中的作用,
与LATS 1/2和NF 2的相关性; 3)研究PLD 1-NFPA轴在LATS 1/2调节中的作用,
对河马上游信号的响应。总的来说,我们提出的研究将揭示一个关键的监管
响应Hippo上游信号传导控制LATS 1/2激活的机制,概念上
通过填补这一知识空白来推进我们对河马途径的理解。
英文摘要
PROJECT SUMMARY
Over the past decades, the Hippo pathway has been recognized as a crucial signaling pathway that
controls organ and tissue size, by restricting cell proliferation and anti-apoptosis. The Hippo pathway can be
regulated by a wide range of extracellular signaling, including perceived physical signals from cell
microenvironment (i.e. contact inhibition, cell polarity, cytoskeleton-based mechanical cues), growth
factors/mitogenic hormones (i.e. LPA and S1P regulated GPCR signaling), and recently discovered metabolic
status (i.e. energy stress, hypoxia). Mechanistically, almost all these stimuli or conditions operate YAP activity
through LATS1/2 kinases. The major knowledge gap for current Hippo signaling comes from the
uncharacterized mechanism for LATS1/2 regulation. The overall objective of this proposal is to elucidate the
regulatory mechanism for LATS1/2 kinases in response to Hippo upstream signaling events.
The detailed regulatory mechanism for LATS1/2 kinases could be complex, since multiple upstream
kinases including MST1/2, MAP4Ks, TAO1-3, are able to phosphorylate LATS1/2 and required for LATS1/2
activation. It is still unclear how these identified kinases are coordinated to transduce upstream signaling to
activate LATS1/2. Besides, small Rho GTPase together with F-actin can sense upstream signaling to modulate
LATS1/2 activities, however, the underlying mechanism is also largely unknown. Therefore, over the past few
years, we have conducted a proteomic analysis of the major components and regulators in the Hippo pathway
to pursue the answer to these questions. Unfortunately, our findings and findings from other labs failed
identifying such a putative “mediator” to fill the current knowledge gap in the Hippo pathway. Unexpectedly and
excitingly, our preliminary studies have discovered phosphatidic acid (PA) and it related lipid signaling as a
critical signaling axis involved in the Hippo pathway regulation. PA could function as a second messenger to
directly associate with LATS1/2 kinases and regulate LATS1/2 activities. Remarkably, PA’s level as well as the
activity of PLD1, a key enzyme that catalyzes PA production, are both decreased in response to the Hippo-
activating stimuli or conditions. On the basis of these observations, we hypothesized that PLD1-PA axis could
play a crucial role in regulation of LATS1/2 activities. Specifically, we propose to 1) determine the role of PA in
YAP regulation, particularly focusing on the independent role of PA from LPA in YAP activation;; 2) elucidate
the mechanism by which PA activates YAP. We will dissect the role of PA in LATS1/2 suppression through its
association with LATS1/2 and NF2;; and 3) investigate the role of PLD1-PA axis in LATS1/2 regulation in
response to Hippo upstream signaling. Collectively, our proposed study will reveal a crucial regulatory
mechanism to control LATS1/2 activation in response to the Hippo upstream signaling and conceptually
advance our understanding of the Hippo pathway by filling this knowledge gap.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting the role of Hippo signaling in platinum-based chemotherapy
-
批准号:10311544
-
项目类别:
-
资助金额:$23.55万
-
财政年份:2020
-
负责人:Wenqi Wang
-
依托单位:
Regulation and function of the Hippo pathway in growth control
-
批准号:10584267
-
项目类别:
-
资助金额:$32.34万
-
财政年份:2018
-
负责人:Wenqi Wang
-
依托单位:
Lipid signaling in Hippo pathway regulation
-
批准号:10117918
-
项目类别:
-
资助金额:$4.55万
-
财政年份:2018
-
负责人:Wenqi Wang
-
依托单位:
Lipid signaling in Hippo pathway regulation
-
批准号:10093079
-
项目类别:
-
资助金额:$38.71万
-
财政年份:2018
-
负责人:Wenqi Wang
-
依托单位:
Lipid signaling in Hippo pathway regulation
-
批准号:10552388
-
项目类别:
-
资助金额:$3.25万
-
财政年份:2018
-
负责人:Wenqi Wang
-
依托单位:
海外基金